After leucovorin got public attention as a potential autism treatment, families rushed to get it. Many doctors are torn about prescribing an unproven drug but don’t want to lose patients’ trust. Michal Ruprecht, a Stanford Global Health Media Fellow, reports for NPR.
Michal Ruprecht is the 2025-26 Stanford Global Health Media Fellow and a fourth-year medical student at Wayne State University School of Medicine. He previously worked at NPR as the AAAS Mass Media Fellow and has interned with ABC News, MedPage Today and the American Public Health Association. Prior to that, Michal was a reporter at The Michigan Daily, the University of Michigan’s independent daily student newspaper. Beyond reporting, Michal is a member of the Association of Health Care Journalists membership committee. Michal graduated with honors and a B.S. in neuroscience from the University of Michigan in 2022, where he leveraged community action and social change to partner with individuals affected by the Flint water crisis. He serves on the boards of the Michigan Chapter of the American Academy of Pediatrics and Riley’s Way Foundation.
